Kay Fink

2.2k total citations
27 papers, 1.7k citations indexed

About

Kay Fink is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, Kay Fink has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Infectious Diseases. Recurrent topics in Kay Fink's work include Biochemical and Molecular Research (7 papers), Erythrocyte Function and Pathophysiology (4 papers) and HIV/AIDS drug development and treatment (4 papers). Kay Fink is often cited by papers focused on Biochemical and Molecular Research (7 papers), Erythrocyte Function and Pathophysiology (4 papers) and HIV/AIDS drug development and treatment (4 papers). Kay Fink collaborates with scholars based in United States, Slovakia and Croatia. Kay Fink's co-authors include R. M. Fink, Robert M. Fink, Richard E. Cline, W. Stirk Adams, Robert B. Henderson, R. E. Cline, William N. Valentine, Charles McGaughey, Donald E. Paglia and Susan R. Harris and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kay Fink

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Fink United States 19 1.1k 296 259 172 164 27 1.7k
K.K. Tsuboi United States 26 1.0k 0.9× 321 1.1× 115 0.4× 147 0.9× 85 0.5× 69 1.9k
Herman Μ. Kalckar United States 27 1.3k 1.2× 295 1.0× 293 1.1× 563 3.3× 179 1.1× 64 2.4k
Hans Klenow Denmark 24 1.6k 1.4× 127 0.4× 78 0.3× 188 1.1× 155 0.9× 56 2.2k
K. Lemone Yielding United States 27 1.3k 1.2× 193 0.7× 67 0.3× 465 2.7× 249 1.5× 92 2.3k
Leonard C. Harber United States 32 1.3k 1.2× 140 0.5× 398 1.5× 31 0.2× 116 0.7× 87 3.0k
Ernst A. Noltmann United States 27 1.4k 1.3× 655 2.2× 119 0.5× 191 1.1× 116 0.7× 61 2.4k
William A. Creasey United States 24 872 0.8× 118 0.4× 102 0.4× 71 0.4× 217 1.3× 64 1.9k
Donald E. Hultquist United States 23 1.0k 0.9× 372 1.3× 454 1.8× 140 0.8× 49 0.3× 60 2.0k
Henry Borsook United States 20 760 0.7× 465 1.6× 112 0.4× 87 0.5× 75 0.5× 43 1.7k
D.R. Grassetti United States 14 735 0.7× 150 0.5× 51 0.2× 209 1.2× 164 1.0× 21 1.4k

Countries citing papers authored by Kay Fink

Since Specialization
Citations

This map shows the geographic impact of Kay Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Fink more than expected).

Fields of papers citing papers by Kay Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Fink. The network helps show where Kay Fink may publish in the future.

Co-authorship network of co-authors of Kay Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Fink. A scholar is included among the top collaborators of Kay Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Fink. Kay Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peinemann, Klaus‐Viktor, Kay Fink, & Peter J. Witt. (1986). Asymmetric polyetherimide membrane for helium separation. Journal of Membrane Science. 27(2). 215–216. 16 indexed citations
2.
Paglia, Donald E., Kay Fink, & William N. Valentine. (1980). Additional Data from Two Kindreds with Genetically Induced Deficiencies of Erythrocyte Pyrimidine Nucleotidase. Acta Haematologica. 63(5). 262–267. 10 indexed citations
3.
Drevenkar, Vlasta, et al.. (1976). The fate of pesticides in aquatic environment. II. Hydrolysis of dichlorvos in a model system and in river water.. PubMed. 27(4). 297–305. 2 indexed citations
4.
Valentine, William N., Kay Fink, Donald E. Paglia, Susan R. Harris, & W. Stirk Adams. (1974). Hereditary Hemolytic Anemia with Human Erythrocyte Pyrimidine 5′-Nucleotidase Deficiency. Journal of Clinical Investigation. 54(4). 866–879. 213 indexed citations
5.
Fink, Kay & W. Stirk Adams. (1968). Urinary purines and pyrimidines in normal and leukemic subjects. Archives of Biochemistry and Biophysics. 126(1). 27–33. 35 indexed citations
6.
Fink, Kay & W. Stirk Adams. (1966). Paper chromatography data for purines, pyrimidines and derivatives in a variety of solvents. Journal of Chromatography A. 22(1). 118–129. 74 indexed citations
7.
Fink, Kay, R. E. Cline, & R. M. Fink. (1963). Paper Chromatography of Several Classes of Compounds: Correlated Rf Values in a Variety of Solvent Systems. Analytical Chemistry. 35(3). 389–398. 166 indexed citations
8.
Fink, Robert M. & Kay Fink. (1962). Relative Retention of H3 and C14 Labels of Nucleosides Incorporated into Nucleic Acids of Neurospora. Journal of Biological Chemistry. 237(9). 2889–2891. 45 indexed citations
9.
Fink, Robert M. & Kay Fink. (1962). Utilization of Radiocarbon from Thymidine and Other Precursors of Ribonucleic Acid in Neurospora crassa. Journal of Biological Chemistry. 237(7). 2289–2290. 28 indexed citations
10.
Fink, R. M. & Kay Fink. (1961). Biosynthesis of radioactive RNA and DNA pyrimidines from thymidine-2-C-14. Biochemical and Biophysical Research Communications. 6(1). 7–10. 17 indexed citations
11.
Cline, Richard E., Robert M. Fink, & Kay Fink. (1959). Synthesis of 5-Substituted Pyrimidines via Formaldehyde Addition1. Journal of the American Chemical Society. 81(10). 2521–2527. 179 indexed citations
12.
Fink, Kay, et al.. (1957). The excretion of beta-aminoisobutyric acid in normal, mongoloid and non-mongoloid mentally defective children.. PubMed. 61(3). 530–3. 6 indexed citations
13.
Fink, R. M., R. E. Cline, Charles McGaughey, & Kay Fink. (1956). Chromatography of Pyrimidine Reduction Products. Analytical Chemistry. 28(1). 4–6. 116 indexed citations
14.
Fink, Kay, Richard E. Cline, Robert B. Henderson, & Robert M. Fink. (1956). METABOLISM OF THYMINE (METHYL-C14 OR −2-C14) BY RAT LIVER IN VITRO. Journal of Biological Chemistry. 221(1). 425–433. 174 indexed citations
15.
Fink, Kay. (1956). EXCRETION OF PYRIMIDINE REDUCTION PRODUCTS BY THE RAT. Journal of Biological Chemistry. 218(1). 9–14. 34 indexed citations
16.
Fink, R. M., Charles McGaughey, Richard E. Cline, & Kay Fink. (1956). METABOLISM OF INTERMEDIATE PYRIMIDINE REDUCTION PRODUCTS IN VITRO. Journal of Biological Chemistry. 218(1). 1–7. 111 indexed citations
17.
Henderson, Robert B., R. M. Fink, & Kay Fink. (1955). Synthesis of Thymine (Methyl-C14)1. Journal of the American Chemical Society. 77(23). 6381–6382. 5 indexed citations
18.
Fink, R. M., Kay Fink, & Robert B. Henderson. (1953). β-AMINO ACID FORMATION BY TISSUE SLICES INCUBATED WITH PYRIMIDINES. Journal of Biological Chemistry. 201(1). 349–355. 83 indexed citations
19.
Fink, Kay, Robert B. Henderson, & R. M. Fink. (1952). β-AMINOISOBUTYRIC ACID IN RAT URINE FOLLOWING ADMINISTRATION OF PYRIMIDINES. Journal of Biological Chemistry. 197(1). 441–452. 69 indexed citations
20.
Fink, Kay. (1951). A Substance Occasionally Found as a Major Ninhydrin-Reacting Component of Urine.. Experimental Biology and Medicine. 76(4). 692–695. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026